5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The Sydney system for lymph node FNA biopsy cytopathology: A detailed analysis of recent publications and meta‐analysis and a proposal for the components of an ideal prospective study of a cytopathology reporting system

      review-article
      , MB, BS, FRCPA 1 , 2 , , MD 3 , , MD 4 , , MB, BS(Hons), FRCPA, FIAC 1 , 2 , 5 ,
      Cancer Cytopathology
      John Wiley and Sons Inc.
      fine‐needle aspiration cytology, lymph nodes, risk of malignancy, Sydney system

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          The Sydney system for fine‐needle aspiration biopsy of lymph nodes has five categories, stressing the role of correlation of cytopathology with clinical, ultrasound, and ancillary findings to achieve diagnosis. The five categories constitute a hierarchical system with increasing risk of malignancy from benign to atypical, suspicious, and malignant categories, which informs recommendations for further workup to achieve a final diagnosis as possible. This article analyzes 10 publications using the Sydney system and a meta‐analysis of nine of these studies. The primary goal of the analysis is to ascertain the causes of the large ranges in risk of malignancy for the “atypical” and “inadequate” compared to “benign,” “suspicious,” and “malignant” categories, which were comparable to well‐established reporting systems. Research protocols are proposed to improve future studies.

          Methods

          PubMed literature search from January 2021 to December 2023 identified studies evaluating performance of the Sydney system.

          Results

          Ten studies showed heterogeneity with clinical setting, study design, ultrasound use and rapid on‐site evaluation, operator, cutoff points for “positive” cases, with inherent partial verification biases, resulting in a wide range of risk of malignancy, specificity, and sensitivity values.

          Conclusion

          Analysis shows the large range is due to heterogeneity of the studies, which suffer from biases and variable statistical analysis that are ultimately included in any meta‐analysis, detracting from the usefulness of the risk of malignancy derived by the meta‐analysis. Components for ideal analyses of reporting systems are presented.

          Abstract

          The Sydney system for lymph node cytopathology shows variable risk of malignancy with commendable specificity whereas its sensitivity is relatively moderate. There is a marked heterogeneity among the published studies on this topic that raises concerns about the generalizability of the findings in a recent meta‐analysis of the Sydney system. The authors propose a framework of what data should be included in an ideal analysis of the Sydney system, which may be used in a review of any other reporting system.

          Related collections

          Most cited references26

          • Record: found
          • Abstract: found
          • Article: not found

          The 2023 Bethesda System for Reporting Thyroid Cytopathology

          Since the publication of the first edition in 2010, The Bethesda System for Reporting Thyroid Cytopathology has allowed cytopathologists to use a standardized, category-based reporting system for thyroid fine needle aspirations. The third edition builds on the success of the 2 earlier editions and offers several key updates. The most important is the assignment of a single name for each of the 6 diagnostic categories: (i) nondiagnostic; (ii) benign; (iii) atypia of undetermined significance; (iv) follicular neoplasm; (v) suspicious for malignancy; and (vi) malignant. Each of the categories has an implied risk of malignancy (ROM), which has been updated and refined based on data reported after the second edition. The third edition offers an average ROM for each category, in addition to the expected range of cancer risk. The atypia of undetermined significance subcategorization is simplified into 2 subgroups based on the implied ROM and molecular profiling. A discussion of pediatric thyroid disease has been added, and pediatric ROMs and management algorithms are discussed in the relevant sections. Nomenclature has been updated to align with the 2022 World Health Organization Classification of Thyroid Neoplasms. Two new chapters have been added: one that addresses the significant and expanded use of molecular and ancillary testing in thyroid cytopathology, and another that summarizes clinical perspectives and imaging findings in thyroid disease.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The International Academy of Cytology Yokohama System for Reporting Breast Fine-Needle Aspiration Biopsy Cytopathology.

            The International Academy of Cytology (IAC) gathered together a group of cytopathologists expert in breast cytology who, working with clinicians expert in breast diagnostics and management, have developed the IAC Yokohama System for Reporting Breast Fine-Needle Aspiration Biopsy (FNAB) Cytology. The project was initiated with the first cytopathology group meeting in Yokohama at the 2016 International Congress of Cytology. This IAC Yokohama System defines five categories for reporting breast cytology, each with a clear descriptive term for the category, a definition, a risk of malignancy (ROM) and a suggested management algorithm. The key diagnostic cytopathology features of each of the lesions within each category will be presented more fully in a subsequent atlas. The System emphasizes that the crucial requirements for diagnostic breast FNAB cytology are a high standard for the performance of the FNAB and for the making of direct smears, and well-trained experienced cytopathologists to interpret the material. The performance indicators of breast FNAB, including specificity and sensitivity, negative predictive value, positive predictive value and ROM stated in this article have been derived from the recent literature. The current practice of breast FNAB has evolved with the increasing use of ultrasound guidance and rapid on-site evaluation. Two recent publications have shown a range of ROM for the insufficient/inadequate category of 2.6-4.8%, benign 1.4-2.3%, atypical 13-15.7%, suspicious of malignancy 84.6-97.1%, and malignant 99.0-100%. The management algorithm in the System provides options because there are variations in the management of breast lesions using FNAB and core-needle biopsy in those countries utilizing the "triple test" of clinical, imaging, and FNAB assessment, and also variations in the availability of CNB and imaging in low- and middle-income countries. The System will stimulate further discussion and research, particularly in the cytological diagnostic features of specific lesions within each category and in management recommendations. This will lead to continuing improvements in the care of patients with breast lesions and possible modifications to the IAC Yokohama System.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              A Proposal for the Performance, Classification, and Reporting of Lymph Node Fine-Needle Aspiration Cytopathology: The Sydney System.

              The evaluation of lymph nodes (LN) by fine-needle aspiration cytology (FNAC) is routinely used in many institutions but it is not uniformly accepted mainly because of the lack of guidelines and a cytopathological diagnostic classification. A committee of cytopathologists has developed a system of performance, classification, and reporting for LN-FNAC.
                Bookmark

                Author and article information

                Contributors
                Andrew.field@svha.org.au
                Journal
                Cancer Cytopathol
                Cancer Cytopathol
                10.1002/(ISSN)1934-6638
                CNCY
                Cancer Cytopathology
                John Wiley and Sons Inc. (Hoboken )
                1934-662X
                1934-6638
                04 August 2024
                December 2024
                : 132
                : 12 ( doiID: 10.1002/cncy.v132.12 )
                : 745-756
                Affiliations
                [ 1 ] Department of Anatomical Pathology St. Vincent’s Hospital and University of NSW Sydney New South Wales Australia
                [ 2 ] Medical School, University of NSW Sydney Sydney New South Wales Australia
                [ 3 ] Vanvitalli University of Naples Naples Italy
                [ 4 ] University of Salerno Pathology Institute AOU San Giovanni di Dio e Ruggi d’Aragona Salerno, Fisciano Italy
                [ 5 ] Medical School, Notre Dame University Sydney Sydney New South Wales Australia
                Author notes
                [*] [* ] Correspondence

                Andrew S. Field, Department of Anatomical Pathology, St. Vincent’s Hospital, Sydney, and University of NSW Sydney and University of Notre Dame Sydney, Victoria Street, Darlinghurst 2020, Australia.

                Email: Andrew.field@ 123456svha.org.au

                Author information
                https://orcid.org/0000-0002-5324-2826
                https://orcid.org/0000-0001-7358-5925
                https://orcid.org/0000-0001-9604-4507
                Article
                CNCY22890
                10.1002/cncy.22890
                11610793
                39097796
                09c347fe-cd24-49ff-bb62-9cd108f09a3c
                © 2024 The Author(s). Cancer Cytopathology published by Wiley Periodicals LLC on behalf of American Cancer Society.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

                History
                : 25 June 2024
                : 04 March 2024
                : 09 July 2024
                Page count
                Figures: 0, Tables: 7, Pages: 12, Words: 8894
                Categories
                Review Article
                Review Article
                Custom metadata
                2.0
                December 2024
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.1 mode:remove_FC converted:02.12.2024

                fine‐needle aspiration cytology,lymph nodes,risk of malignancy,sydney system

                Comments

                Comment on this article